Literature DB >> 31054745

ACR Appropriateness Criteria® Noninvasive Clinical Staging of Primary Lung Cancer.

Patricia M de Groot1, Jonathan H Chung2, Jeanne B Ackman3, Mark F Berry4, Brett W Carter5, Patrick M Colletti6, Stephen B Hobbs7, Barbara L McComb8, Benjamin Movsas9, Betty C Tong10, Christopher M Walker11, Sue S Yom12, Jeffrey P Kanne13.   

Abstract

Lung cancer is the leading cause of cancer-related deaths in both men and women. The major risk factor for lung cancer is personal tobacco smoking, particularly for small-cell lung cancer (SCLC) and squamous cell lung cancers, but other significant risk factors include exposure to secondhand smoke, environmental radon, occupational exposures, and air pollution. Education and socioeconomic status affect both incidence and outcomes. Non-small-cell lung cancer (NSCLC), including adenocarcinoma, squamous cell carcinoma, and large cell carcinoma, comprises about 85% of lung cancers. SCLC accounts for approximately 13% to 15% of cases. Prognosis is directly related to stage at presentation. NSCLC is staged using the eighth edition of the tumor-node-metastasis (TNM) criteria of the American Joint Committee on Cancer. For SCLC the eighth edition of TNM staging is recommended to be used in conjunction with the modified Veterans Administration Lung Study Group classification system distinguishing limited stage from extensive stage SCLC. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
Copyright © 2019 American College of Radiology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  8th edition TNM lung cancer; AUC; Appropriate Use Criteria; Appropriateness Criteria; Lung cancer staging; Non–small cell lung cancer; Small-cell lung cancer

Mesh:

Substances:

Year:  2019        PMID: 31054745     DOI: 10.1016/j.jacr.2019.02.008

Source DB:  PubMed          Journal:  J Am Coll Radiol        ISSN: 1546-1440            Impact factor:   5.532


  9 in total

1.  Ethnic Disparities in Imaging Utilization at Diagnosis of Non-Small Cell Lung Cancer.

Authors:  Rustain L Morgan; Sana D Karam; Cathy J Bradley
Journal:  J Natl Cancer Inst       Date:  2020-12-14       Impact factor: 13.506

Review 2.  Bone metastases in non-small cell lung cancer: a narrative review.

Authors:  Brendan J Knapp; Siddhartha Devarakonda; Ramaswamy Govindan
Journal:  J Thorac Dis       Date:  2022-05       Impact factor: 3.005

Review 3.  Consistency of recommendations for the diagnosis and treatment of non-small cell lung cancer: a systematic review.

Authors:  Zhe Zhang; Sen Yang; Yanfang Ma; Hanqiong Zhou; Xuan Wu; Jing Han; Jiabao Hou; Lidan Hao; Jonathan D Spicer; Young Wha Koh; Mariano Provencio; Noemi Reguart; Tetsuya Mitsudomi; Qiming Wang
Journal:  Transl Lung Cancer Res       Date:  2021-06

4.  Two weeks of hydrogen inhalation can significantly reverse adaptive and innate immune system senescence patients with advanced non-small cell lung cancer: a self-controlled study.

Authors:  Ji-Bing Chen; Xiao-Feng Kong; Wei Qian; Feng Mu; Tian-Yu Lu; You-Yong Lu; Ke-Cheng Xu
Journal:  Med Gas Res       Date:  2020 Oct-Dec

5.  [Korean Clinical Imaging Guidelines for the Appropriate Use of Chest MRI].

Authors:  Jiyoung Song; Bo Da Nam; Soon Ho Yoon; Jin Young Yoo; Yeon Joo Jeong; Chang Dong Yeo; Seong Yong Lim; Sung Yong Lee; Hyun Koo Kim; Byoung Hyuck Kim; Kwang Nam Jin; Hwan Seok Yong
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2021-05-20

6.  Age does matter in adolescents and young adults vs. older adults with lung adenocarcinoma: A retrospective analysis comparing clinical characteristics and outcomes in response to systematic treatments.

Authors:  Lin Zhou; Huiwu Li; Shuhui Yang
Journal:  Oncol Lett       Date:  2022-08-31       Impact factor: 3.111

7.  Evaluation of the reporting quality of clinical practice guidelines on lung cancer using the RIGHT checklist.

Authors:  Yongjie Yang; Jingli Lu; Yanfang Ma; Chen Xi; Jian Kang; Qiwen Zhang; Xuedong Jia; Kefeng Liu; Shuzhang Du; Florian Kocher; Andreas Seeber; Cesare Gridelli; Mariano Provencio; Nobuhiko Seki; Yusuke Tomita; Xiaojian Zhang
Journal:  Transl Lung Cancer Res       Date:  2021-06

8.  Crosstalk between let-7a-5p and BCL-xL in the Initiation of Toxic Autophagy in Lung Cancer.

Authors:  Shuyin Duan; Junxia Li; Jiaqi Tian; Haoyu Yin; Qingfeng Zhai; Yongjun Wu; Sanqiao Yao; Lin Zhang
Journal:  Mol Ther Oncolytics       Date:  2019-09-10       Impact factor: 7.200

9.  Hydrogen therapy can be used to control tumor progression and alleviate the adverse events of medications in patients with advanced non-small cell lung cancer.

Authors:  Ji-Bing Chen; Xiao-Feng Kong; Feng Mu; Tian-Yu Lu; You-Yong Lu; Ke-Cheng Xu
Journal:  Med Gas Res       Date:  2020 Apr-Jun
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.